A groundbreaking shift in the country's drug policy has occurred, as the regulators announce the availability of psilocybin fungi for therapeutic treatment. Until now, these substances were heavily restricted, but a increasing body of studies suggests they could offer relief for emotional illnesses like depression. This development represents a maj